Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354510
Status:
COMPLETED
Last Update Posted:
2012-06-04
First Post:
2006-07-18
Brief Title:
Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Randomised Double-blind Placebo-controlled Study of Topical GW842470X Formulation in Adults With Moderate Atopic Dermatitis
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the clinical efficacy of 3 ww GW842470X cream applied to involved skin of adult patients with moderate atopic dermatitis using the Eczema Area Severity Index EASI assessment of disease severity and to investigate the safety of and tolerability of 3 GW842470X cream on diseased skin of adult patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None